SUSQUEHANNA INTERNATIONAL GROUP, LLP - PEREGRINE PHARMACEUTICALS IN ownership

PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 85 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of PEREGRINE PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$71,000
+373.3%
117,327
+416.9%
0.00%
Q1 2017$15,000
-31.8%
22,700
-68.2%
0.00%
Q4 2016$22,000
+340.0%
71,411
+532.0%
0.00%
Q3 2016$5,000
+25.0%
11,3000.0%0.00%
Q2 2016$4,000
-94.1%
11,300
-93.1%
0.00%
Q1 2016$68,000
-72.5%
163,696
-22.6%
0.00%
Q4 2015$247,000
-10.8%
211,493
-21.9%
0.00%
Q3 2015$277,000
-30.1%
270,725
-10.5%
0.00%
Q2 2015$396,000
+50.0%
302,552
+54.4%
0.00%
Q1 2015$264,000
-22.8%
195,924
-20.3%
0.00%
Q4 2014$342,000
-45.1%
245,884
-46.3%
0.00%
Q3 2014$623,000
-37.5%
458,201
-13.6%
0.00%
Q2 2014$997,000
-0.8%
530,424
+0.3%
0.00%
Q1 2014$1,005,000
+344.7%
528,726
+224.9%
0.00%
Q4 2013$226,000
-16.6%
162,720
-15.6%
0.00%
Q3 2013$271,000
-63.0%
192,777
-66.1%
0.00%
Q2 2013$733,000569,3550.00%
Other shareholders
PEREGRINE PHARMACEUTICALS IN shareholders Q2 2014
NameSharesValueWeighting ↓
BAXTER BROS INC 170,506$232,0000.09%
First Heartland Consultants, Inc. 86,204$117,0000.05%
Rotella Capital Management, Inc. 20,769$28,0000.03%
FIDGEON TIMOTHY F 33,000$45,0000.02%
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC 547,800$746,0000.02%
Freedom Investment Management, Inc. 74,127$101,0000.02%
Investors Capital Advisory Services 63,288$86,0000.02%
REYNOLDS CAPITAL MANAGEMENT LLC 10,000$14,0000.01%
Tower Research Capital LLC (TRC) 76,914$104,0000.01%
PINNACLE FINANCIAL PARTNERS INC 20,000$27,0000.01%
View complete list of PEREGRINE PHARMACEUTICALS IN shareholders